Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

碘化油 医学 肝细胞癌 经导管动脉化疗栓塞 随机对照试验 栓塞 临床终点 单变量分析 外科 内科学 胃肠病学 多元分析
作者
Chung‐Mau Lo,Hys Ngan,Wai‐Kuen Tso,Chi‐Leung Liu,Chi‐Ming Lam,Ronnie T. P. Poon,Sheung-Tat Fan,John Wong
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:35 (5): 1164-1171 被引量:2726
标识
DOI:10.1053/jhep.2002.33156
摘要

This randomized, controlled trial assessed the efficacy of transarterial Lipiodol (Lipiodol Ultrafluide, Laboratoire Guerbet, Aulnay-Sous-Bois, France) chemoembolization in patients with unresectable hepatocellular carcinoma. From March 1996 to October 1997, 80 out of 279 Asian patients with newly diagnosed unresectable hepatocellular carcinoma fulfilled the entry criteria and randomly were assigned to treatment with chemoembolization using a variable dose of an emulsion of cisplatin in Lipiodol and gelatin-sponge particles injected through the hepatic artery (chemoembolization group, 40 patients) or symptomatic treatment (control group, 40 patients). One patient assigned to the control group secondarily was excluded because of unrecognized systemic metastasis. Chemoembolization was repeated every 2 to 3 months unless there was evidence of contraindications or progressive disease. Survival was the main end point. The chemoembolization group received a total of 192 courses of chemoembolization with a median of 4.5 (range, 1-15) courses per patient. Chemoembolization resulted in a marked tumor response, and the actuarial survival was significantly better in the chemoembolization group (1 year, 57%; 2 years, 31%; 3 years, 26%) than in the control group (1 year, 32%; 2 years, 11%; 3 years, 3%; P =.002). When adjustments for baseline variables that were prognostic on univariate analysis were made with a multivariate Cox model, the survival benefit of chemoembolization remained significant (relative risk of death, 0.49; 95% CI, 0.29-0.81; P =.006). Although death from liver failure was more frequent in patients who received chemoembolization, the liver functions of the survivors were not significantly different. In conclusion, in Asian patients with unresectable hepatocellular carcinoma, transarterial Lipiodol chemoembolization significantly improves survival and is an effective form of treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
liangchenglyu发布了新的文献求助10
1秒前
csy完成签到,获得积分10
1秒前
3秒前
如意连碧完成签到,获得积分10
3秒前
wangdl_2000完成签到,获得积分10
3秒前
3秒前
3秒前
3秒前
可爱的函函的应助被function采纳,获得10
3秒前
净心完成签到,获得积分10
3秒前
4秒前
4秒前
ioi完成签到 ,获得积分10
4秒前
4秒前
supperhappy完成签到,获得积分10
5秒前
chms发布了新的文献求助10
6秒前
6秒前
无极微光的应助被ayeben采纳,获得20
6秒前
CodeCraft的应助被胡萝卜卜采纳,获得10
6秒前
葡萄关注了科研通微信公众号
6秒前
舒心的雨双完成签到,获得积分10
7秒前
BOBO发布了新的文献求助10
7秒前
7秒前
明理飞风完成签到,获得积分10
7秒前
8秒前
大成子发布了新的文献求助10
8秒前
刘一完成签到 ,获得积分10
9秒前
科研究极进化完成签到,获得积分10
9秒前
molihuakai的应助被xxxxxxxxxx采纳,获得10
9秒前
桐桐的应助被Yancy采纳,获得100
9秒前
Wei发布了新的文献求助10
9秒前
DD发布了新的文献求助10
9秒前
freecare发布了新的文献求助10
9秒前
NexusExplorer的应助被梁小伟采纳,获得10
9秒前
无糖加冰完成签到,获得积分10
9秒前
10秒前
Yuyu001发布了新的文献求助80
10秒前
珍蚌好命女完成签到,获得积分10
10秒前
inertia完成签到,获得积分10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193425
求助须知:如何正确求助?哪些是违规求助? 9579620
关于积分的说明 21866505
捐赠科研通 7793025
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560718
邀请新用户注册赠送积分活动 2484128